RedHill Biopharma Drug Gets FDA Boost for Treating Childhood Cancer
RedHill Biopharma's investigational drug opaganib has received FDA rare pediatric disease designation for treating neuroblastoma in children.
U.S. Food and Drug Administration
Israel’s MeMed Wins FDA Breakthrough Status for AI-Powered Infection Test
Haifa-based MeMed's AI-powered MeMed BV Flex test, distinguishing bacterial from viral infections in 15 minutes, earns FDA Breakthrough Device Designation.
Israeli MedTech Firm Bendit Wins FDA Approval for Steerable Microcatheter
Israeli MedTech firm Bendit secures FDA approval for its revolutionary Bendit17 Microcatheter, enhancing precision in complex vascular procedures.
Navigation